- Home
- KROS vs NAK Comparison
KROS vs NAK Comparison
Compare KROS & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NAK
- Stock Information
- Founded
- KROS 2015
- NAK 1983
- Country
- KROS United States
- NAK Canada
- Employees
- KROS N/A
- NAK N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NAK Precious Metals
- Sector
- KROS Health Care
- NAK Basic Materials
- Exchange
- KROS Nasdaq
- NAK Nasdaq
- Market Cap
- KROS 565.0M
- NAK 481.8M
- IPO Year
- KROS 2020
- NAK 2002
- Fundamental
- Price
- KROS $15.66
- NAK $0.82
- Analyst Decision
- KROS Buy
- NAK Strong Buy
- Analyst Count
- KROS 14
- NAK 1
- Target Price
- KROS $20.56
- NAK $2.50
- AVG Volume (30 Days)
- KROS 430.7K
- NAK 3.9M
- Earning Date
- KROS 11-05-2025
- NAK 08-13-2025
- Dividend Yield
- KROS N/A
- NAK N/A
- EPS Growth
- KROS N/A
- NAK N/A
- EPS
- KROS 0.47
- NAK N/A
- Revenue
- KROS $232,844,000.00
- NAK N/A
- Revenue This Year
- KROS $5,579.44
- NAK N/A
- Revenue Next Year
- KROS N/A
- NAK N/A
- P/E Ratio
- KROS $33.65
- NAK N/A
- Revenue Growth
- KROS 85820.30
- NAK N/A
- 52 Week Low
- KROS $9.12
- NAK $0.30
- 52 Week High
- KROS $72.37
- NAK $2.40
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- NAK 39.06
- Support Level
- KROS $15.23
- NAK $0.81
- Resistance Level
- KROS $15.85
- NAK $0.94
- Average True Range (ATR)
- KROS 0.52
- NAK 0.03
- MACD
- KROS 0.01
- NAK 0.01
- Stochastic Oscillator
- KROS 72.91
- NAK 19.58
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NAK Northern Dynasty Minerals Ltd.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.